Chronic nodular prurigo: clinical profile and burden. A European cross-sectional study.
Journal
Journal of the European Academy of Dermatology and Venereology : JEADV
ISSN: 1468-3083
Titre abrégé: J Eur Acad Dermatol Venereol
Pays: England
ID NLM: 9216037
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
received:
30
09
2019
accepted:
27
01
2020
pubmed:
23
2
2020
medline:
15
5
2021
entrez:
21
2
2020
Statut:
ppublish
Résumé
Chronic nodular prurigo (CNPG) is a condition characterized by chronic itch, a prolonged scratching behaviour and the presence of pruriginous nodules. A comprehensive understanding of this condition, especially regarding its clinical characteristics and impact on quality of life is still lacking. Aim of this pan-European multicentre cross-sectional study was to establish the clinical profile of CNPG, including its associated burden. Fifteen centres from 12 European countries recruited CNPG patients presenting at the centre or using the centres' own databases. Patients were asked to complete a questionnaire in paper or electronic format. Demography, current co-morbidities, underlying disease, itch intensity, additional sensory symptoms, quality of life, highest burden and emotional experience of itch were assessed. A total of 509 patients (210 male, median age: 64 years [52; 72]) were enrolled. Of these, 406 reported itch and CNPG lesions in the previous 7 days and qualified to complete the whole questionnaire. We recorded moderate to severe worst itch intensity scores in the previous 24 h. Scores were higher in patients with lower educational levels and those coming from Eastern or Southern Europe. Most patients experience itch often or always (71%) and report that their everyday life is negatively affected (53%). Itch intensity was considered to be the most burdensome aspect of the disease by 49% of the patients, followed by the visibility of skin lesions (21%) and bleeding of lesions (21%). The majority of patients was unaware of an underlying condition contributing to CNPG (64%), while psychiatric diseases were the conditions most often mentioned in association with CNPG (19%). This multicentre cross-sectional study shows that itch is the dominant symptom in CNPG and reveals that the profile of the disease is similar throughout Europe.
Sections du résumé
BACKGROUND
BACKGROUND
Chronic nodular prurigo (CNPG) is a condition characterized by chronic itch, a prolonged scratching behaviour and the presence of pruriginous nodules. A comprehensive understanding of this condition, especially regarding its clinical characteristics and impact on quality of life is still lacking.
OBJECTIVES
OBJECTIVE
Aim of this pan-European multicentre cross-sectional study was to establish the clinical profile of CNPG, including its associated burden.
METHODS
METHODS
Fifteen centres from 12 European countries recruited CNPG patients presenting at the centre or using the centres' own databases. Patients were asked to complete a questionnaire in paper or electronic format. Demography, current co-morbidities, underlying disease, itch intensity, additional sensory symptoms, quality of life, highest burden and emotional experience of itch were assessed.
RESULTS
RESULTS
A total of 509 patients (210 male, median age: 64 years [52; 72]) were enrolled. Of these, 406 reported itch and CNPG lesions in the previous 7 days and qualified to complete the whole questionnaire. We recorded moderate to severe worst itch intensity scores in the previous 24 h. Scores were higher in patients with lower educational levels and those coming from Eastern or Southern Europe. Most patients experience itch often or always (71%) and report that their everyday life is negatively affected (53%). Itch intensity was considered to be the most burdensome aspect of the disease by 49% of the patients, followed by the visibility of skin lesions (21%) and bleeding of lesions (21%). The majority of patients was unaware of an underlying condition contributing to CNPG (64%), while psychiatric diseases were the conditions most often mentioned in association with CNPG (19%).
CONCLUSIONS
CONCLUSIONS
This multicentre cross-sectional study shows that itch is the dominant symptom in CNPG and reveals that the profile of the disease is similar throughout Europe.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2373-2383Subventions
Organisme : European Academy of Dermatology and Venereology
ID : 2016-012
Investigateurs
F Dalgard
(F)
J Elberling
(J)
C Forner
(C)
T Leslie
(T)
C Riepe
(C)
G Schneider
(G)
H Ständer
(H)
Informations de copyright
© 2020 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology.
Références
Pereira MP, Steinke S, Zeidler C et al. European academy of dermatology and venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo. J Eur Acad Dermatol Venereol 2018; 32: 1059-1065.
Pereira MP, Zeidler C, Nau T et al. Position statement: linear prurigo is a subtype of chronic prurigo. J Eur Acad Dermatol Venereol 2019; 33: 263-266.
Stander S, Weisshaar E, Mettang T et al. Clinical classification of itch: a position paper of the international forum for the study of itch. Acta Derm Venereol 2007; 87: 291-294.
Zeidler C, Stander S. The pathogenesis of Prurigo nodularis - 'Super-Itch' in exploration. Eur J Pain 2016; 20: 37-40.
Storck M, Zeidler C, Rehr M et al. Validation of pruritus measures gathered with the electronic patient-reported outcome system MoPat. Acta Derm Venereol 2018; 98: 38-43.
Jones J, Hunter D. Consensus methods for medical and health services research. BMJ 1995; 311: 376-380.
Phan NQ, Blome C, Fritz F et al. Assessment of pruritus intensity: prospective study on validity and reliability of the visual analogue scale, numerical rating scale and verbal rating scale in 471 patients with chronic pruritus. Acta Derm Venereol 2012; 92: 502-507.
Zeidler C, Stander S. Kurzfragebogen zur Lebensqualität bei chronischem Pruritus: ein neues Instrument zur Nutzung in der Praxis. 50 Tagung der Deutschen Dermatologischen Gesellschaft, Vereinigung Deutschsprachiger Dermatologen e.V. Berlin, 2019: 64-79.
Schut C, Dalgard FJ, Halvorsen JA et al. Occurrence, chronicity and intensity of itch in a clinical consecutive sample of patients with skin diseases: a multi-centre study in 13 European Countries. Acta Derm Venereol 2019; 99: 146-151.
Carr CW, Veledar E, Chen SC. Factors mediating the impact of chronic pruritus on quality of life. JAMA Dermatol 2014; 150: 613-620.
Misery L, Brenaut E, Le Garrec R et al. Neuropathic pruritus. Nat Rev Neurol 2014; 10: 408-416.
Pogatzki-Zahn EM, Pereira MP, Cremer A et al. Peripheral sensitisation and loss of descending inhibition is a hallmark of chronic pruritus. J Invest Dermatol 2020; 140: 203-211.
Iking A, Grundmann S, Chatzigeorgakidis E et al. Prurigo as a symptom of atopic and non-atopic diseases: aetiological survey in a consecutive cohort of 108 patients. J Eur Acad Dermatol Venereol 2013; 27: 550-557.
Snaith RP. The hospital anxiety and depression scale. Health Qual Life Outcomes 2003; 1: 29.
Brenaut E, Halvorsen JA, Dalgard FJ et al. The self-assessed psychological comorbidities of prurigo in European patients: a multicentre study in 13 countries. J Eur Acad Dermatol Venereol 2019; 33: 157-162.
Schneider G, Hockmann J, Stander S et al. Psychological factors in prurigo nodularis in comparison with psoriasis vulgaris: results of a case-control study. Br J Dermatol 2006; 154: 61-66.
Jorgensen KM, Egeberg A, Gislason GH et al. Anxiety, depression and suicide in patients with prurigo nodularis. J Eur Acad Dermatol Venereol 2017; 31: e106-e107.
Dhawan L, Singh SM, Avasthi A et al. The prevalence of psychiatric comorbidity in patients with prurigo nodularis. Indian Dermatol Online J 2018; 9: 318-321.
Schneider G, Driesch G, Heuft G et al. Psychosomatic cofactors and psychiatric comorbidity in patients with chronic itch. Clin Exp Dermatol 2006; 31: 762-767.
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
Dalgard FJ, Svensson A Halvorsen JA et al. Itch and mental health in dermatological patients across Europe: a cross sectional study in 13 countries. J Invest Dermatol 2019; 140: 568-573.
Zeidler C, Steinke S, Riepe C et al. Cross-European validation of the ItchyQoL in pruritic dermatoses. J Eur Acad Dermatol Venereol 2019; 33: 391-397.
Boozalis E, Tang O, Patel S et al. Ethnic differences and comorbidities of 909 prurigo nodularis patients. J Am Acad Dermatol 2018; 79: 714-719.e3.
Larson VA, Tang O, Stander S et al. Association between itch and cancer in 16,925 patients with pruritus: experience at a tertiary care center. J Am Acad Dermatol 2019; 80: 931-937.
Steinke S, Zeidler C, Riepe C et al. Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: results of the European Academy of Dermatology and Venereology Network on Assessment of Severity and Burden of Pruritus (PruNet) cross-sectional trial. J Am Acad Dermatol 2018; 79: 457-463.e5.